Indigo Diabetes N.V. (Indigo) is a pioneering developer of medical devices for people living with chronic diseases. Using its proprietary nanophotonics technology the Company is developing the world’s first subcutaneously implanted Continuous Multi-Metabolite Monitoring (CMM®)  sensor to provide people living with chronic diseases access to information on their metabolite levels at any time, without the need to wear an external device on their body. Indigo is initially focused on diabetes to address the need for continuous and accurate glucose, ketone, and lactate monitoring.  Indigo is headquartered in Ghent, Belgium, and also has employees based in the US.

Fidimec

Manuardeo

imec.xpand

Ackermans & van Haaren

Parana Management

Qbic Fund

SoFi

Thuja Capital

Titan Baratto

Indigo

Exciting News! 🎉 Thrilled to share that our CEO, Danaë Delbeke, has been recognized among the 100 Most Prominent Women in Belgian Media. 🌟 
Her leadership and impact continue to inspire us all. Congratulations Danaë! 🙌 Check out the full list here: https://lnkd.in/dkZ7UJU7

#leadership  #inspiration #media

Our CEO, Danaë Delbeke, presented at the Life Science Intelligence, Emerging MedTech Summit Europe in September where she talked about our  continuous multi-metabolite monitoring (CMM®) sensor, the only standalone implanted device in development capable of monitoring multiple metabolites continuously.

To watch a replay of her presentation, please follow the link below:
https://lnkd.in/e_eUPVFu

#LSIEurope23 #diabetes #healthcareinnovation 

The Music4Diabetes Consortium launched a new project to improve Type 1 Diabetes treatment by developing an implantable multi-metabolite sensor connected to a pump that delivers insulin continuously.

We are proud to be one of the seven consortium members to be spearheading this project which has already benefitted from a prestigious €3.8m European Innovation Council pathway programme grant.

The new website for the MuSiC4Diabetes project is live! Find out more here: https://lnkd.in/eSqrF6FJ

#MuSiC4Diabetes #DiabetesInnovation #HealthTech #Type1Diabetes #LaunchDay


Today is #worlddiabetesday  with this year’s theme being ‘access to diabetes care’. People with diabetes require ongoing care and support to manage their condition and avoid complications. 
 
That is why at Indigo, we are dedicated to improving the quality of life of people living with diabetes through accurate and continuous glucose, ketone and lactate monitoring. 

Find out more about our technology here: https://lnkd.in/eGtXv8Hm

#worlddiabetesday  #diabetes #medtech #indigo 

Next week, on November 14, is #worlddiabetesday . This year is particularly special as it marks 100 years since scientists, Frederick Banting and John Macleod, were awarded a Nobel Prize in 1923 for the discovery of insulin. 
 
100 years on, we continue to look for advances to help people with diabetes. Indigo’s CMM® implantable sensor monitors multiple metabolites continuously, providing valuable intelligence that can help guide treatment decisions. 

Follow this link to find out more about Indigo Diabetes:  https://indigomed.com

#worlddiabetesday  #diabetesawareness #medtechinnovation 

Developer of needle-free glucose sensors using photonics technology for accurate and low-cost glucose monitoring systems.

Needle-Free Glucose Sensors Company

Belgian medtech company developing medical applications based on nanophotonics.

Unnamed Medtech Company

Indigo is a pioneer in developing a continuous multi-metabolite monitoring (CMM®) system for chronic disease management, initially focusing on diabetes through continuous glucose, ketone, and lactate monitoring. The company's nanophotonics technology allows for the implantation of a small sensor under the skin, providing real-time data to aid in disease management.

Indigo Diabetes N.V.

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general	Mar 5, 2024 4:12 AM	882af9c9
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Mar 5, 2024 4:12 AM	73763e3b
company summary	general
signals	general
crunchbase trigger	general	Nov 27, 2024 12:50 PM	bc50b2fb
crunchbase profile	general	Nov 27, 2024 2:21 PM	4cb3e330
li profile	general	Mar 5, 2024 4:12 AM	bd095922
translate crunchbase fundingrounds	general
peers	general
news basic	general	Mar 5, 2024 4:12 AM	93d50259
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:INDIGOMED

Indigo Diabetes N.V.